期刊文献+

Ki67抗原在卵巢肿瘤组织中的表达及与临床病理参数的关系 被引量:7

Study on the expression of Ki67 antigen in ovarian tumors:Correlations of clinical and pathological parameters.
下载PDF
导出
摘要 目的 :探讨卵巢肿瘤中增殖细胞相关核抗原Ki67的表达及意义。方法 :采用流式细胞术检测Ki67抗原在 5 2例卵巢肿瘤组织中的表达。结果 :卵巢癌组织中Ki67表达显著高于卵巢良性肿瘤 (P <0 0 1)。Ki67的表达随组织学分级 (P <0 0 1)、临床分期(P <0 0 5 )的升高而增加。Ki67与卵巢癌肿瘤大小呈正相关 (r =0 4 99,P =0 0 0 6)。结论 :Ki67与卵巢癌的组织学分级、临床分期及肿瘤大小有关。 Objective:To study the expression of Ki67 in human ovarian tumors.Methods:The expressions of proliferation cell nuclear antigen Ki67 were measured in 32 cases of ovarian cancer tissues and 20 cases of benign ovarian tumor tissues using flow cytometry.Results:The expression of Ki67 in ovarian cancer was higher than that in benign ovarian tumor (P<0 01) The expression of Ki67 increased with histological grade (P<0 01) and clinical stage(P<0 05).There was a positive correlation between Ki67 expression and tumor size (r=0.499,P=0.006).Conclusion:Ki67 is correlated with histological grade, clinical stage and tumor size in ovarian cancer.
出处 《现代妇产科进展》 CSCD 2001年第5期362-363,共2页 Progress in Obstetrics and Gynecology
关键词 KI67抗原 卵巢肿瘤 流式细胞术 病理学 Antigen,Ki67 Ovarian neoplasms Flow cytometry Pathology,clinical
  • 相关文献

参考文献5

  • 1Schluter C,Duchrow M,Woblenberg C,et al.The cell proliferation ass ociated antigen of antibody Ki67:A very large ubiquitous nuclear protein with nu merous repeated elements representing a new kind of cell cycle-maintaining prot eins[J].J Cell Biol,1993,23:5131
  • 2Garzetti GG,Ciavattini A,Goteri G,et al.Ki67 antigen immunostainin g(MIB-1 monoclonal antibody) index of proliferative activity with prognostic si gnificance in serous ovarian tumors[J].Gynecol Oncol,1995,56:169-174
  • 3Leonardi E,Girlando Serio G,et al.PCNA and Ki67 expression in breast carcinoma:Correlations with clinical and biological variables[J].J Cli n Pathol,1992,45:416-419
  • 4钱洪流,宗永生,张昌卿.鼻咽癌中p53蛋白积聚的生物学特征和临床意义[J].临床与实验病理学杂志,1996,12(1):15-18. 被引量:20
  • 5Goff BA,Ries JB,Els LP,et al.Immunophenotype of ovarian cancer as predictor of clinical outcome:evaluation at primary surgery and second-look pro cedure[J].Gynecol Oncol,1998,70:378-385

共引文献19

同被引文献59

  • 1宋和存,向征,李慧.Survivin Ki67在卵巢原发癌与转移癌中的表达及其临床意义[J].中国实用妇科与产科杂志,2006,22(3):201-203. 被引量:8
  • 2任琼珍,钱志红,胡建铭.Ki67在卵巢癌中的表达及临床意义[J].苏州大学学报(医学版),2006,26(2):321-321. 被引量:9
  • 3罗珉,李克.p73基因与肿瘤的关系[J].国际肿瘤学杂志,2006,33(3):170-173. 被引量:4
  • 4周俊林,赵建洪,何宁,董驰.颅内血管外皮细胞瘤与血管瘤型脑膜瘤的MRI与病理对照[J].中国临床医学影像杂志,2006,17(12):669-672. 被引量:29
  • 5Stefansson IM,Salvesen HB,Immervoll H,et al. Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type[ J]. Histopathology, 2004,44 ( 5 ) :472-479.
  • 6KAERN J,TROPE C,A GHMESHEH M,et al. A study of prognostic parameters predicting long-term survival in stage Ⅲ epithelial ovarian cancer[J]. Int J Gancer,2004,14( 1 ) :60-66.
  • 7Concin N, Hefler L,van Bavel J,et al. Biological markers in pT1 and pT2 ovarian cancer with lymph node metastaces [ J ]. Gyneeol Oncol, 2003,89( 1 ) ;9-15.
  • 8Bar JK,Grelewski P,Popiela A,et al. Type Ⅳ collagen and CD44v6 expression in benign, malignant primal' and metastatic ovarian tumors;correlation with Ki67 and p53 immunoreactivity [ J ]. Gynecol Oncol,2004,95 ( 1 ) :23-31.
  • 9Costa MJ ,Walls J ,Ames P ,et al. Transformation in recurrent ovarian granulosa cell tumors: Ki67 (MIBI) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histoputhologie prediction of clinical behavior[ J] . Hum Pathol , 1996 ,27 (3) :274 -281.
  • 10S. F. Adams, D. A. Levine,etal. Ki67 expression as a predictor for suboptimally debulked patients with advanced epithelial ovarian cancer[ J]. Journal of Clinical Oncology, 2007, 25 (18S) : 55-63.

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部